Cancer screening

February 10, 2023

From the Co-Chairs, February 2023

Plans for the year ahead; a focus on data; the future of cancer screening studies
April 15, 2022

Enrollment in TMIST Breast Cancer Screening Trial Surpasses Halfway Mark; Recruitment of Women from Diverse Backgrounds is Key to Success

Enrollment doubles in past 17 months due to specific efforts — Black participation rises above 20%
July 7, 2021

Trial Updates: TMIST Enrollment Hits 50,000; NCI-MATCH News; Recent Research Results

Recent ECOG-ACRIN trial updates and results
May 28, 2021

From the Co-Chairs, May 2021

Virtual Spring 2021 Group Meeting generates record attendance; screening and genomic trials return to full activity
February 25, 2021

From the Co-Chairs, February 2021

COVID-19 vaccination and patients with cancer; the impact of delayed screening; a virtual Spring 2021 Group Meeting
October 19, 2020

TMIST Breast Cancer Screening Trial Rebounds from COVID-19 Shutdown of Cancer Screenings

October accrual is on pace to be the highest month on record. Since July 1, TMIST has enrolled more patients than all other National Cancer Institute clinical trials combined. An unheard-of number (nearly 20%) are Black and African American women. Drs. Etta Pisano and Mitch Schnall provide the latest status of the trial and discuss its continuing relevance
June 10, 2020

The Value of TMIST Compared to Other Breast Cancer Screening Studies

TMIST will provide data that is critical for relating the increased rate of detection of early breast cancers to the clinical outcomes of the screening population
February 28, 2020

From the Co-Chairs, February 2020

January meeting with NCI leaders and the Cooperative Group Chairs; Congress increases NCI and overall NIH budget for FY 2020; EA opens two new trials, one for pancreatic cyst monitoring (EA2185) and the other to evaluate nivolumab in head and neck cancer (EA3161); plans are underway for the next Comis Symposium
January 14, 2020

From the Co-Chairs, December 2019/January 2020

Reflecting on key milestones in 2019: TMIST breast cancer screening trial continues to ramp up; NCORP grant renewal emphasizes screening, symptom control, and cancer care delivery research; new role for Dr. Al Benson; E1912's practice-changing trial results; update on Dr. Otis Brawley's efforts to form the Social Determinants of Health Working Group; EA launches the Comis Symposium